Synchron

New York, NY · Founded 2016 · Privately Held (backing)

Developer of an implantable stent-rode designed to create a brain-computer interface. Synchron is based in New York, NY and was founded in 2016. It was valued at $385 million at its later-stage round in Dec 2022, the last priced event on record. It has raised $340 million across 1 recorded round; the latest was a $49.9 million early-stage round in Nov 2022.

PMV mark · valuation
$385.0M
Oct 2026
Priced at
its later-stage round
Dec 2022
Total raised
$339.9M
Last round
Early Stage VC
Nov 2022
Cap table — not yet on record

Synchron's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Pro
The prices on Synchron
  • ·Every dated print: 11 trades with prices and structures
  • ·4 investment vehicles formed around Synchron: sponsors, sizes, dates
Pro · $99 a month
List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Frequently asked about Synchron

Where does Synchron's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Synchron's 1 recorded funding rounds.